Literature DB >> 6239854

Teicoplanin.

A H Williams, R N Grüneberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6239854

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  25 in total

1.  Clinical efficacy of teicoplanin.

Authors:  P Calain; F Waldvogel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-02       Impact factor: 3.267

2.  Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection.

Authors:  J D Knudsen; K Fuursted; S Raber; F Espersen; N Frimodt-Moller
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

3.  Poor efficacy of teicoplanin in treatment of deep-seated staphylococcal infections.

Authors:  N Galanakis; H Giamarellou; N Vlachogiannis; C Dendrinos; G K Daikos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

4.  A40926, a new glycopeptide antibiotic with anti-Neisseria activity.

Authors:  B P Goldstein; E Selva; L Gastaldo; M Berti; R Pallanza; F Ripamonti; P Ferrari; M Denaro; V Arioli; G Cassani
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

5.  The use of a new glycopeptide antibiotic, teicoplanin, in the treatment of bacterial endocarditis.

Authors:  A Webster; A P Wilson; A H Williams; T Treasure; R N Grüneberg
Journal:  Postgrad Med J       Date:  1987-08       Impact factor: 2.401

6.  Evaluation of teicoplanin and vancomycin disk susceptibility tests.

Authors:  A L Barry; C Thornsberry; R N Jones
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

7.  Determination of teicoplanin concentrations in serum by high-pressure liquid chromatography.

Authors:  B Joos; R Lüthy
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

8.  Pharmacokinetics of teicoplanin in patients on continuous ambulatory peritoneal dialysis.

Authors:  G L Traina; M G Gentile; G Fellin; R Rosina; L Cavenaghi; G Buniva; M Bonati
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives?

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

Review 10.  Current problems of chemotherapy of infections with coagulase-negative staphylococci.

Authors:  A J Davies; J W Stone
Journal:  Eur J Clin Microbiol       Date:  1986-06       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.